Biotech stories

OpenAI expands its enterprise AI push with a biology-focused model aimed at speeding target discovery, analysis and early drug development.

British Business Bank makes GBP £100 million first close commitment to Apposite Healthcare Growth I, aiming to fill the UK's life sciences scale-up gap.

Kvantify names Dr David Siebert as global head of business development as it steps up commercial push for hybrid quantum-classical software.

US AI megadeals push global venture capital to a record USD $330.9 billion as OpenAI, Anthropic and xAI dominate first-quarter funding.

ACTO rolls out role-based AI SuperAgents for life sciences field teams, aiming to speed compliant access to approved content across sales and medical work.

Helical secures USD $10 million seed round to scale its AI-powered drug discovery platform across more pharma programmes.

British Business Bank adds GBP £10 million to Empirical Ventures to back deeptech 'venture scientists' and widen early-stage funding beyond London.

Iran-linked wiper cyber attack cripples Stryker plants, disrupting implant production and locking thousands of staff out of global networks.

Wilbe launches flexible life sciences lab hub in White City to tackle early-stage startup space crunch and back scientist founders.

Biotech's next leaders will be defined less by scientific breakthroughs and more by diverse teams building resilient clinical infrastructure.

Belfast tech firm SciLeads will create 60 fully remote roles over three years as it scales its life sciences market intelligence platform.

British Business Bank pledges up to GBP £50 million to IQ Capital Fund V, reinforcing a 20-year partnership backing UK deep tech.

Anthropic rolls out Claude for Healthcare and Life Sciences, adding sector-specific connectors, agent skills and consumer health integrations.

ScotlandIS flags AI, skills, green data centres and cyber basics as critical to Scotland's digital economy amid 2026 uncertainty.

Perforce CTO Rod Cope predicts context and agentic AI will transform coding, jobs and security as ambient systems quietly permeate daily life.

Tech giants including Amazon, Google, and Nvidia pledge GBP £31 billion to boost the UK's AI and cloud infrastructure with new data centres and funding.

Nebius Group has raised USD $4.3 billion to enhance its AI infrastructure and support expansion into Asia, focusing on biotech and drug discovery.

Biostate AI's K-Dense Beta, an AI research system, slashes biological research times from years to weeks, proven through Harvard Medical School longevity studies.

AI-powered predictive risk scores are revolutionising disease prevention by enabling early detection and personalised health interventions before symptoms arise.

Swiss Deep Tech startups have surpassed USD $100 billion in value, boosted by strong venture capital and academic innovation in AI, biotech, and space sectors.